Caption Management, LLC Biotechnology

Caption Management, LLC

  • $9.8 Billion
  • Q4 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
ARGX
Argenx Se
CALL
$63.7 Million
104K
Q2 2024
New holding
INSM
Insmed Inc
PUT
$29.7 Million
431K
Q4 2024
Added 253.23%
CYTK
Cytokinetics Inc
CALL
$25.8 Million
549K
Q4 2024
Added 63.67%
INSM
Insmed Inc
CALL
$25.1 Million
363K
Q4 2024
Added 253.23%
MDGL
Madrigal Pharmaceuticals, Inc.
PUT
$25 Million
81.1K
Q3 2024
New holding
APLS
Apellis Pharmaceuticals, Inc.
CALL
$21.3 Million
667K
Q3 2024
Reduced 49.77%
ACLX
Arcellx, Inc.
PUT
$20.5 Million
269K
Q3 2024
New holding
AXSM
Axsome Therapeutics, Inc.
PUT
$18.6 Million
220K
Q4 2024
Added 1056.86%
NUVL
Nuvalent, Inc.
CALL
$16.7 Million
214K N/A
NVO
Novo Nordisk A S
CALL
$15.9 Million
185K
Q4 2024
Added 659.61%
KRYS
Krystal Biotech, Inc.
CALL
$12.3 Million
78.5K
Q4 2024
New holding
VRNA
Verona Pharma PLC
CALL
$12 Million
258K
Q3 2024
New holding
PCVX
Vaxcyte, Inc.
CALL
$11.9 Million
146K
Q4 2024
Reduced 45.19%
AXSM
Axsome Therapeutics, Inc.
CALL
$10.9 Million
129K
Q4 2024
Added 1056.86%
SRRK
Scholar Rock Holding Corp
PUT
$10.8 Million
251K
Q4 2024
New holding
NVO
Novo Nordisk A S
PUT
$10.8 Million
125K
Q4 2024
Added 659.61%
SRPT
Sarepta Therapeutics, Inc.
PUT
$10.3 Million
85K
Q4 2024
Reduced 18.06%
ARVN
Arvinas, Inc.
CALL
$10.1 Million
527K
Q4 2024
New holding
RVMD
Revolution Medicines, Inc.
PUT
$10.1 Million
230K
Q4 2024
New holding
VRDN
Viridian Therapeutics, Inc.\De
PUT
$9.91 Million
517K
Q4 2024
New holding
CLDX
Celldex Therapeutics, Inc.
CALL
$9.43 Million
373K
Q4 2024
Reduced 93.22%
MDGL
Madrigal Pharmaceuticals, Inc.
CALL
$9.26 Million
30K
Q3 2024
New holding
RARE
Ultragenyx Pharmaceutical Inc.
PUT
$8.52 Million
203K
Q4 2024
Added 1267.1%
ACLX
Arcellx, Inc.
CALL
$8 Million
105K
Q3 2024
New holding
CAPR
Capricor Therapeutics, Inc.
PUT
$7.98 Million
576K N/A
EWTX
Edgewise Therapeutics, Inc.
CALL
$7.96 Million
298K N/A
UTHR
United Therapeutics Corp
CALL
$7.06 Million
20K
Q3 2022
New holding
UTHR
United Therapeutics Corp
PUT
$7.06 Million
20K
Q3 2022
New holding
KRYS
Krystal Biotech, Inc.
PUT
$7 Million
44.7K
Q4 2024
New holding
ITOS
I Teos Therapeutics, Inc.
PUT
$5.84 Million
761K
Q4 2024
New holding
NUVL
Nuvalent, Inc.
PUT
$5.68 Million
72.6K N/A
CORT
Corcept Therapeutics Inc
PUT
$5.29 Million
105K
Q1 2024
New holding
CAPR
Capricor Therapeutics, Inc.
CALL
$5.24 Million
378K N/A
PLRX
Pliant Therapeutics, Inc.
PUT
$5.2 Million
395K
Q4 2024
New holding
CRSP
Crispr Therapeutics Ag
PUT
$5.06 Million
129K
Q4 2024
Added 4159.17%
EXEL
Exelixis, Inc.
PUT
$5 Million
150K
Q3 2024
Added 122.43%
PCVX
Vaxcyte, Inc.
PUT
$4.91 Million
60K
Q4 2024
Reduced 45.19%
AGIO
Agios Pharmaceuticals, Inc.
PUT
$4.85 Million
148K
Q4 2024
Added 126.17%
SNDX
Syndax Pharmaceuticals Inc
PUT
$4.75 Million
359K
Q4 2024
Added 956.12%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$4.71 Million
20K
Q3 2024
Reduced 95.07%
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$4.71 Million
20K
Q3 2024
Reduced 95.07%
TGTX
Tg Therapeutics, Inc.
PUT
$4.69 Million
156K
Q3 2023
New holding
AUPH
Aurinia Pharmaceuticals Inc.
PUT
$4.53 Million
504K
Q4 2024
New holding
ASND
Ascendis Pharma A/S
PUT
$4.13 Million
30K
Q4 2024
New holding
CORT
Corcept Therapeutics Inc
CALL
$4.11 Million
81.5K
Q1 2024
New holding
CRSP
Crispr Therapeutics Ag
CALL
$3.96 Million
101K
Q4 2024
Added 4159.17%
QURE
Uni Qure N.V.
CALL
$3.92 Million
222K
Q3 2024
New holding
ARWR
Arrowhead Pharmaceuticals, Inc.
CALL
$3.85 Million
205K
Q3 2024
Reduced 88.87%
BBIO
Bridge Bio Pharma, Inc.
CALL
$3.84 Million
140K
Q4 2024
Reduced 63.5%
Filter Shares Options
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email